Michael Monaghan
Pfizer
1 Papers
Michael Monaghan is an academic researcher from Pfizer. The author has contributed to research in topics: Neurodegeneration & Parkinson's disease. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease.
Katrina L. Paumier,Stacey J. Sukoff Rizzo,Zdenek Berger,Yi Chen,Cathleen Gonzales,Edward Kaftan,Li Li,Susan M. Lotarski,Michael Monaghan,Wei Shen,Polina Stolyar,Dmytro Vasilyev,Margaret M. Zaleska,Warren D. Hirst,John Dunlop +14 more
TL;DR: Results from open field and rotarod tests show A53T mice develop age-dependent changes in locomotor activity and reduced anxiety-like behavior, and digigait analysis shows these mice develop an abnormal gait by 12 months of age, which may provide useful endpoints for assessing novel therapeutic interventions for PD.